Compliance News Week Ending April 11, 2025
In this Article
Final CMS Instructions - Changes to Simplified Method Determinations for 2026
Employers that provide prescription drug coverage are not required to offer creditable coverage but are required to determine whether the coverage is creditable and to communicate creditable status annually to eligible individuals and to the Centers for Medicare & Medicaid Services (CMS).
Prescription drug coverage is creditable if the actuarial value of the coverage equals or exceeds the actuarial value of Medicare Part D coverage.
Most plan sponsors have the option to determine creditable status by obtaining an actuarial determination or by using a “simplified method” as defined by CMS. CMS final instructions released earlier this week set forth revised criteria for the simplified method.
A plan must meet all of the following to be creditable:
- Must provide reasonable coverage for brand name and generic prescription drugs and biological products;
- Must provide reasonable access to retail pharmacies; and
- Must be designed to pay on average at least 72% of participants’ prescription drug expenses.
For 2026 plan years, CMS will permit plans to use either the existing simplified determination methodology or the revised simplified determination methodology described above to determine whether prescription drug coverage under their CY 2026 plans is creditable.
While every effort has been taken in compiling this information to ensure that its contents are totally accurate, neither the publisher nor the author can accept liability for any inaccuracies or changed circumstances of any information herein or for the consequences of any reliance placed upon it. This publication is distributed on the understanding that the publisher is not engaged in rendering legal, accounting, or other professional advice or services. Readers should always seek professional advice before entering into any commitments.